For: | Donlon NE, Davern M, O’Connell F, Sheppard A, Heeran A, Bhardwaj A, Butler C, Narayanasamy R, Donohoe C, Phelan JJ, Lynam-Lennon N, Dunne MR, Maher S, O’Sullivan J, Reynolds JV, Lysaght J. Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma. World J Gastroenterol 2022; 28(21): 2302-2319 [PMID: 35800186 DOI: 10.3748/wjg.v28.i21.2302] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i21/2302.htm |
Number | Citing Articles |
1 |
Clemence J. Belle, James M. Lonie, Sandra Brosda, Andrew P. Barbour. Tumour microenvironment influences response to treatment in oesophageal adenocarcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1330635
|
2 |
Maria Davern, Noel E. Donlon, Andrew S. Sheppard, Klaudia D. Majcher, Fiona O’ Connell, Aisling B. Heeran, Malika Grant, Robert A. Farrell, Conall Hayes, Dara Bracken-Clarke, Melissa J. Conroy, Emma Foley, Dermot O’ Toole, Anshul Bhardwaj, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Jacintha O’ Sullivan, Joanne Lysaght. FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy. Journal of Cancer Research and Clinical Oncology 2023; 149(7): 3753 doi: 10.1007/s00432-022-04283-9
|
3 |
Navin Pinto, Catherine M. Albert, Mallory R. Taylor, Heidi B. Ullom, Ashley L. Wilson, Wenjun Huang, Jason Wendler, Sowmya Pattabhi, Kristy Seidel, Christopher Brown, Joshua A. Gustafson, Stephanie D. Rawlings-Rhea, Safia H.E. Cheeney, Katelyn Burleigh, Heather H. Gustafson, Rimas J. Orentas, Nicholas A. Vitanza, Rebecca A. Gardner, Michael C. Jensen, Julie R. Park. STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors. Journal of Clinical Oncology 2024; 42(35): 4163 doi: 10.1200/JCO.23.02229
|
4 |
Heidi Kussmann. Cancer Care in the United Arab Emirates. 2024; : 313 doi: 10.1007/978-981-99-6794-0_19
|
5 |
Zhendong Liu, Haigang Chang, Xingbo Cheng, Qingnan Wang, Rongjun Qian, Yanzheng Gao. Potential Value of Expression of Receptor Accessory Protein 4 in Lower - Grade Glioma For Antitumor Immunotherapy. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4198096
|
6 |
Pengcheng Liu, Xiaobing Wang, Aishe Dun, Yutong Li, Houqiang Li, Lu Wang, Yichun Zhang, Cancan Li, Jinxia Zhang, Xiaoyu Zhang, Lixing Ma, Haifeng Hou. High-Throughput Profiling of Serological Immunoglobulin G N-Glycome as a Noninvasive Biomarker of Gastrointestinal Cancers. Engineering 2023; 26: 44 doi: 10.1016/j.eng.2023.02.008
|
7 |
Senbo Liu, Wenkang Wang, Shengyun Hu, Bin Jia, Baojing Tuo, Haifeng Sun, Qiming Wang, Yang Liu, Zhenqiang Sun. Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity. Cell Death & Disease 2023; 14(10) doi: 10.1038/s41419-023-06211-2
|
8 |
Maria Davern, Cillian O’ Donovan, Noel E. Donlon, Eimear Mylod, Caoimhe Gaughan, Anshul Bhardwaj, Andrew D. Sheppard, Dara Bracken-Clarke, Christine Butler, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds, Joanne Lysaght, Melissa J. Conroy. Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma. Biomedicines 2024; 12(4): 819 doi: 10.3390/biomedicines12040819
|
9 |
Maria Davern, Noel E. Donlon. The future of combination immunotherapy in oesophageal adenocarcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1217132
|